Letter to the editor: antidiabetics--drug labeling.
D000284:Administration, Oral; D004348:Drug Labeling; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D014044:Tolbutamide / Q000009:adverse effects; D014481:United States; D014486:United States Food and Drug Administration
D007004:Hypoglycemic Agents; D014044:Tolbutamide